Your browser doesn't support javascript.
loading
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma.
Yang, Weixiong; Xing, Xiangbin; Yeung, Sai-Ching Jim; Wang, Siyu; Chen, Wenfang; Bao, Yong; Wang, Fang; Feng, Shiting; Peng, Fang; Wang, Xiaoyan; Chen, Shuling; He, Minghui; Zhang, Ning; Wang, Honglei; Zeng, Bo; Liu, Zhenguo; Kidane, Biniam; Seder, Christopher W; Koyanagi, Kazuo; Shargall, Yaron; Luo, Honghe; Peng, Sui; Cheng, Chao.
Afiliación
  • Yang W; Department of Thoracic Surgery, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Xing X; Department of Gastroenterology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Yeung SJ; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang S; Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
  • Chen W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Bao Y; Department of Pathology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Wang F; Department of Radiotherapy, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Feng S; Institute of Precision Medicine, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Peng F; Department of Radiology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Wang X; Department of Radiotherapy, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Chen S; Department of Nuclear Medicine, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • He M; Division of Interventional Ultrasound, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Zhang N; Department of Liver Surgery, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Wang H; Department of Gastroenterology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Zeng B; Department of Pathology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Liu Z; Department of Thoracic Surgery, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Kidane B; Department of Thoracic Surgery, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Seder CW; Department of Surgery, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Koyanagi K; Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
  • Shargall Y; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
  • Luo H; Division of Thoracic Surgery, McMaster University/St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
  • Peng S; Department of Thoracic Surgery, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Cheng C; Clinical Trials Unit and Institute of Precision Medicine, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
J Immunother Cancer ; 10(1)2022 01.
Article en En | MEDLINE | ID: mdl-35022193
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Receptor de Muerte Celular Programada 1 / Carcinoma de Células Escamosas de Esófago Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Receptor de Muerte Celular Programada 1 / Carcinoma de Células Escamosas de Esófago Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido